Form 4 holding
Director, 10%+ Owner
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 4,193,874
- Estimated value
- $2,813,251
- Report date
- 28 Jul 2022
- Price
- $0.6708
- Ownership
- By F2 Capital I 2020 LLC
F2 MG Ltd - Director, 10%+ Owner at Kalaris Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- KLRS on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by F2 MG Ltd since 17 Aug 2025
Reported holdings for F2 MG Ltd in Kalaris Therapeutics, Inc.
Form 4 holding
Director, 10%+ Owner
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 2,059,884
- Estimated value
- $1,381,770
- Report date
- 28 Jul 2022
- Price
- $0.6708
- Ownership
- Direct
Form 4 holding
Director, 10%+ Owner
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 2,038,583
- Estimated value
- $1,367,481
- Report date
- 28 Jul 2022
- Price
- $0.6708
- Ownership
- By F2 MC, LLC
Form 4 holding
Director, 10%+ Owner
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 867,678
- Estimated value
- $582,038
- Report date
- 28 Jul 2022
- Price
- $0.6708
- Ownership
- By F2 Bioscience AV 2022 LLC
Form 4 holding
Director, 10%+ Owner
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 668,072
- Estimated value
- $448,143
- Report date
- 28 Jul 2022
- Price
- $0.6708
- Ownership
- By F2-TPO Investments, LLC
Transaction history for F2 MG Ltd in Kalaris Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.